Navigation Links
UVa biomedical engineering study shows magnetic field can reduce swelling

A recent study by University of Virginia researchers demonstrates that the use of an acute, localized static magnetic field of moderate strength can result in significant reduction of swelling when applied immediately after an inflammatory injury.

Thomas Skalak, professor and chair of biomedical engineering, and Cassandra Morris, a former Ph.D. student in biomedical engineering at U.Va., reported their findings in the November 2007 edition of the American Journal of Physiology.

In the study, the hind paws of anesthetized rats were treated with inflammatory agents in order to simulate tissue injury. Magnetic therapy was then applied to the paws. The research results indicate that magnets can significantly reduce swelling if applied immediately after tissue trauma.

Since muscle bruising and joint sprains are the most common injuries worldwide, this discovery has potentially significant implications. "If an injury doesn't swell, it will heal faster - and the person will experience less pain and better mobility," says Skalak. This means that magnets might be used much the way ice packs and compression are now used for everyday sprains, bumps, and bruises, but with more beneficial results. The ready availability and low cost of this treatment could produce huge gains in worker productivity and quality of life.

Magnets have been touted for their healing properties since ancient Greece. Magnetic therapy is still widely used today as an alternative method for treating a number of conditions, from arthritis to depression, but there hasn't been scientific proof that magnets can heal.

Lack of regulation and widespread public acceptance have turned magnetic therapy into a $5 billion world market. Hopeful consumers buy bracelets, knee braces, shoe inserts, mattresses and other products that are embedded with magnets based on anecdotal evidence, hoping for a non-invasive and drug-free cure to what ails them.

"The Federal Drug Administration regulates specific claims of medical efficacy, but in general static magnetic fields are viewed as safe," notes Skalak, who has been carefully studying magnets for a number of years in order to develop real scientific evidence about the effectiveness of magnetic therapy.

Skalak's lab leads the field in the area of microcirculation research - the study of blood flow through the body's tiniest blood vessels. With a five-year, $875,000 grant from the National Institutes of Health's National Center for Complementary and Alternative Medicine, Skalak and Morris set out to investigate the effect of magnetic therapy on microcirculation. Initially, they sought to examine a major claim made by companies that sell magnets: that magnets increase blood flow.

In their initial study, magnets of 70 milliTesla (mT) field strength - about 10 times the strength of the common refrigerator variety - were placed near the rats' blood vessels. Quantitative measurements of blood vessel diameter were taken both before and after exposure to the static magnetic fields - the force created by the magnets. Morris and Skalak found that the force had a significant effect: the vessels that had been dilated constricted, and the constricted vessels dilated, implying that the magnetic field could induce vessel relaxation in tissues with constrained blood supply, ultimately increasing blood flow.

Dilation of blood vessels is often a major cause of swelling at sites of trauma to soft tissues such as muscles or ligaments. The prior results on vessel constriction led Morris and Skalak to look closer at whether magnets, by limiting blood flow in such cases, would also reduce swelling.

Given the results of this latest study, Skalak envisions the magnets being particularly useful to high school, college and professional sports teams, as well as school nurses and retirement communities. He has plans to continue testing the effectiveness of magnets through clinical trials and testing in elite athletes. A key to the success of magnetic therapy for tissue swelling is careful engineering of the proper field strength at the tissue location, a challenge in which most currently available commercial magnet systems fall short. The new research should allow Skalak's biomedical engineering group to design field strengths that provide real benefit for specific injuries and parts of the body.

"We now hope to implement a series of steps, including private investment partners and eventually a major corporate partner, to realize these very widespread applications that will make a positive difference for human health," says Skalak.


Contact: Jeff Hanna
University of Virginia

Related biology news :

1. Boston University biomedical engineers find chink in bacterias armor
2. $22 million gift from Alfred Taubman launches new biomedical research institute
3. USC biomedical team to participate in $6 million low vision project
4. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
5. Innovative civil engineering application promises cleaner waters
6. UC-San Diego Engineering Honor Society wins most outstanding chapter award
7. UCSD bioengineering grad student wins leadership award
8. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
9. Setting a course for the future of tissue engineering
10. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
11. A study by the MUHC and McGill University opens a new door to understanding cancer
Post Your Comments:
(Date:11/18/2015)... 18, 2015  As new scientific discoveries deepen our ... other healthcare providers face challenges in better using that ... In addition, as more children continue to survive pediatric ... and old age. John M. Maris, M.D ... of Philadelphia (CHOP) . --> John ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced  today ... rights plan (Rights Plan) in an effort to preserve ... under Section 382 of the Internal Revenue Code (Code). ... use of its NOLs could be substantially limited if ... Section 382 of the Code. In general, an ownership ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... 25, 2015 The Global ... a professional and in-depth study on the current ... (Logo: ) , The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
Breaking Biology Technology: